EUVIMEDEUVIMED entdecken
Crossref

Effects of Apigenin Isolated From Christia vespertilionis Leaves on Anti‐SARS‐CoV‐2 Activity: In Silico and In Vitro Studies

Nur Ainina Hani Ghazali, Tavamani Balan, Puvana Devi Selvarajoo, Mohd Ridzuan Mohd Abd Razak, Nurul Batrisya Ruzamri, Sze Wei Leong, Sharon Fatinathan, Vikneswari Perumal iD, Adlin Afzan

Chemistry & Biodiversity · 2025

DOI: 10.1002/cbdv.202500478 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2025. Verfasst von Nur Ainina Hani Ghazali und 8 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmacy and Health Sciences, Royal College of Medicine Perak, Universiti Kuala Lumpur, Ipoh, Perak, Malaysia. Hauptthemen laut MEDLINE: SARS-CoV-2, Antiviral Agents, Apigenin. Die Arbeit nennt 55 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The coronavirus disease (COVID‐19) endemic has urged an intensive search for effective treatments to fight the infections. The lack of effective medication against SARS‐CoV‐2 infections has led to alternative treatment approaches, with medicinal plants as promising candidates in the ongoing development of anti‐SARS‐CoV‐2 therapeutics. In this present study, apigenin‐6‐C‐β‐glucoside‐4′‐O‐α‐apiofuranoside (AGA), a phytochemical compound found in Christia vespertilionis methanolic leaves extract (MeCV) was screened for anti‐SARS‐CoV‐2 via in silico molecular docking approach on angiotensin‐converting enzyme 2 (ACE2) receptor. The methanol extract, fractions, and AGA were assessed for in vitro anti‐SARS‐CoV‐2 assay. Molecular docking analysis showed that AGA (−71.7 kJ/mol) demonstrated potential binding interactions with ACE2 residues comparable to MLN‐4760 (−70.4 kJ/mol), a potent and selective human ACE2 inhibitor. The in vitro result revealed that methanolic extract exhibited the highest antiviral effect compared to other tested samples. These findings suggest that methanol extract contains active antiviral compounds and could be the potential anti‐SARS‐CoV‐2 agent.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SARS-CoV-2Antiviral AgentsApigeninPlant LeavesMolecular Docking SimulationHumansPlant ExtractsAngiotensin-Converting Enzyme 2COVID-19 Drug TreatmentVero CellsCOVID-19

Stichwörter der Autor:innen

COVID‐19Christia vespertilionisSARS‐CoV‐2apigeninisolation

Substanzen

Antiviral AgentsApigeninPlant ExtractsAngiotensin-Converting Enzyme 2ACE2 protein, human

Autor:innen und Institutionen

  • Faculty of Pharmacy and Health Sciences, Royal College of Medicine Perak, Universiti Kuala Lumpur, Ipoh, Perak, Malaysia.
  • Herbal Medicine Research Centre, Institute for Medical Research, National Institutes of Health, Ministry of Health Malaysia, Shah Alam, Selangor, Malaysia.
  • School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia.
  • Department of Chemistry, Faculty of Science, Universiti Malaya, Kuala Lumpur, Malaysia.
  • School of Pharmacy, Management and Science University, Shah Alam, Selangor, Malaysia.

ORCID-Profile: Vikneswari Perumal

Zitieren

APA

Ghazali, N. A. H., Balan, T., Selvarajoo, P. D., Mohd Abd Razak, M. R., Ruzamri, N. B., Leong, S. W., Fatinathan, S., Perumal, V., & Afzan, A. (2025). Effects of Apigenin Isolated From Christia vespertilionis Leaves on Anti‐SARS‐CoV‐2 Activity: In Silico and In Vitro Studies. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202500478

Vancouver

Ghazali NAH, Balan T, Selvarajoo PD, Mohd Abd Razak MR, Ruzamri NB, Leong SW, et al. Effects of Apigenin Isolated From Christia vespertilionis Leaves on Anti‐SARS‐CoV‐2 Activity: In Silico and In Vitro Studies. Chemistry & Biodiversity. 2025. doi:10.1002/cbdv.202500478

BibTeX
@article{Ghazali2025,
  author = {Ghazali, Nur Ainina Hani and Balan, Tavamani and Selvarajoo, Puvana Devi and Mohd Abd Razak, Mohd Ridzuan and Ruzamri, Nurul Batrisya and Leong, Sze Wei and Fatinathan, Sharon and Perumal, Vikneswari and Afzan, Adlin},
  title = {Effects of Apigenin Isolated From Christia vespertilionis Leaves on Anti‐SARS‐CoV‐2 Activity: In Silico and In Vitro Studies},
  journal = {Chemistry & Biodiversity},
  year = {2025},
  doi = {10.1002/cbdv.202500478}
}
Kostenlos starten →